Lipids and Lipoproteins

Introduction to the Lipids and Lipoproteins Unit

This unit covers lipids and lipoproteins over a two-week period.
Week 1 Objectives:
- Familiarization with components of the Lipid Panel.
- Understanding the clinical significance and function of each component.
- Identifying potential causes of abnormalities seen on a Lipid Panel.
Week 2 Preview:
- Screening for cardiovascular disease (CVD) as the primary purpose of the Lipid Panel.
- Discussion of additional tests for cardiovascular disease risk assessment.
- Identification of limitations of the lipid panel and other risk assessments.
- Strategies for clinical management.
Overview of Week 1 Focus: This week serves as an introduction to pathology causing lipid abnormalities and establishing a fundamental understanding of what the panel results represent.

Lipid Overview: Triglycerides and Cholesterol

The primary focus is on triglycerides and cholesterol as they constitute the main components of the lipid panel.
Physicochemical Properties:
- Lipids are defined by their insolubility in water.
- Because cholesterol and triglycerides cannot dissolve in water, they cannot be transported through the blood in their raw form.
- Transport requires specialized vehicles known as lipoproteins.
Lipoprotein Structure:
- Lipoproteins are complex structures combining lipids and proteins.
- They feature integral proteins on the exterior that facilitate the transport of internal components (cholesterol and triglycerides).
- This structure allows for the systemic circulation and delivery of lipids to appropriate locations throughout the body.

Triglycerides: Energy and Insulation

Primary Function: Triglycerides provide essential energy storage for the body.
Energy Conversion:
- When dietary energy intake exceeds the body's immediate metabolic needs, the excess is converted into triglycerides through a process called lipogenesis.
- These triglycerides are then stored in adipose tissue (fatty tissue) as an energy reserve.
Secondary Functions:
- Provides insulation for the body.
- Acts as a protective barrier for internal organs.
- Contributes to cellular membrane fluidity.
- Facilitates the transport of fat-soluble nutrients.

Cholesterol: Synthesis and Physiological Roles

Chemical Classification: Cholesterol is a steroid.
Critical Physiological Functions:
- It is a vital component for maintaining cellular membrane fluidity.
- It serves as a necessary precursor for several physiologically important substances, including:
  - Bile Acids and Salts: Cholesterol is essential for the production of bile acids and serves as a precursor for bile salts.
  - Hormones: It is a precursor for progesterone, Vitamin D, glucocorticoids (e.g., cortisol), and mineralocorticoids.
Sources of Cholesterol:
- De novo Synthesis (Endogenous): This accounts for a large majority of the body's cholesterol, approximately $70\text{--}80\%+$ of total levels. Synthesis occurs primarily in the liver.
- Dietary Intake (Exogenous): Cholesterol is also obtained through the consumption of food.
Genetics vs. Lifestyle:
- Genetics play a significant role in determining cholesterol levels and how the body processes them.
- There is a constant interaction between an individual's genetic predisposition and their lifestyle/dietary impacts.
Elimination: Cholesterol is removed from the system after being converted by the liver into bile acid salts.
Regulation of Synthesis:
- The regulation of de novo synthesis is highly complex.
- Hormonal Regulators: Several hormones influence the amount of cholesterol produced, including:
  - Insulin
  - Thyroid hormone
  - Glucagon
  - Glucocorticoids (such as cortisol)

Categorization of Lipoproteins: ApoB and ApoA

Lipoproteins are categorized based on the specific apoproteins (or apolipoproteins) embedded in their walls.
The ApoB Group (Apolipoprotein B):
- These are characterized by having an integral ApoB protein.
- Members include: Chylomicrons, Very Low Density Lipoprotein ( $VLDL$ ), Intermediate Density Lipoprotein ( $IDL$ ), Low Density Lipoprotein ( $LDL$ ), and $Lp$ (referred to as $LPA$ in clinical risk assessment).
- Atherogenic Properties: These are generally referred to as atherogenic lipoproteins because high levels correlate with the development of atherosclerosis.
- Chylomicron Exception: While categorized as ApoB, chylomicrons are generally not associated with atherogenicity because they are too large to become embedded in vascular walls.
The ApoA Group (Apolipoprotein A):
- These feature an ApoA protein embedded in the wall.
- Primary member: High Density Lipoprotein ( $HDL$ ).
- Cardioprotective Properties: Traditionally considered cardioprotective, though modern research suggests significant nuance.
- Genetic Exception: Individuals with a genetic propensity for extremely high $HDL$ do not necessarily receive cardioprotective benefits; research into these nuances is ongoing.
Misnomers of "Good" vs. "Bad" Cholesterol:
- The terms "good cholesterol" ( $HDL$ ) and "bad cholesterol" ( $LDL$ ) are technically inaccurate.
- The actual cholesterol molecule being carried is identical in both cases.
- The distinction between "good" and "bad" refers to the role and function of the lipoprotein vehicle carrying the cholesterol, not the cholesterol itself.

Detailed Breakdown of Individual Lipoproteins

Chylomicrons:
- The largest physiologic fat particles in the blood.
- Composed primarily of triglycerides ( $exogenous$ transport).
- Origin: Synthesized in intestinal epithelial cells.
- Function: Carry triglycerides from food to adipose cells (for storage) or working cells like muscles (for catabolism).
- Clearance: Takes approximately $12\,\text{hours}$ to clear from systemic circulation.
- Clinical Note: Because of the $12\text{-hour}$ clearance, a non-fasting lipid panel can show falsely elevated triglycerides and skew other calculated values.
Very Low Density Lipoprotein ( $VLDL$ ):
- A major carrier of triglycerides derived endogenously.
- Function: Transports triglycerides from the liver to peripheral tissues.
- Risk: Positive correlation with atherosclerosis (levels increase alongside risk).
Intermediate Density Lipoprotein ( $IDL$ ):
- Formed as $VLDL$ particles release and "dump" triglycerides into tissues, becoming less dense.
- Considered a breakdown component of $VLDL$ .
- Shows a slight positive correlation with atherosclerosis.
Low Density Lipoprotein ( $LDL$ ):
- Formed from $IDL$ as they continue to release triglycerides.
- Composition: Highly cholesterol-rich. Contains approximately $45\%$ cholesterol, $10\%$ triglycerides, $20\%$ phospholipids, and protein in its transport region.
- Function: Delivers cholesterol to peripheral tissues and organs (e.g., adrenal glands for cortisol production or testes for testosterone production).
- Risk: Strongly associated with atherosclerosis as particles can become embedded in vascular walls.
$Lp$ (also called $LPA$ ):
- An $LDL$ particle with an additional lipoprotein attachment wrapping around the ApoB protein.
- Risk: Positive association with atherosclerotic cardiovascular disease.
- Attributes: Highly heritable/genetically determined. Levels remain stable over time and are less responsive to lifestyle changes or standard pharmaceutical interventions.
- Clinical Recommendation: Recommended to be tested at least once in a lifetime for risk assessment.
High Density Lipoprotein ( $HDL$ ):
- Synthesized by the liver and small intestines.
- Composition: Most dense; approximately $50\%$ protein, $1\text{--}5\%$ triglycerides, $15\%$ cholesterol, and $30\%$ phospholipids.
- Function (Reverse Cholesterol Transport): Removes cholesterol from peripheral tissues and transports it back to the liver for excretion.
- Additional Role: Helps prevent the cellular uptake of lipids and cholesterol.
- Risk: Inversely proportional to the risk of Coronary Heart Disease ( $CHD$ ); higher levels generally correlate with lower risk.